IL-3 is a novel target to interfere with tumor vasculature
Por um escritor misterioso
Descrição
Dual-Target Inhibitors Based on HDACs: Novel Antitumor Agents for Cancer Therapy
Cancers, Free Full-Text
The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment, Cancer Cell International
IL-3 is a novel target to interfere with tumor vasculature
Chimeric TIM-4 receptor-modified T cells targeting phosphatidylserine mediates both cytotoxic anti-tumor responses and phagocytic uptake of tumor-associated antigen for T cell cross-presentation: Molecular Therapy
IL-3 signalling in the tumour microenvironment shapes the immune response via tumour endothelial cell-derived extracellular vesicles - ScienceDirect
Tumor-induced neurogenesis and immune evasion as targets of innovative anti- cancer therapies
Defueling the cancer: ATP synthase as an emerging target in cancer therapy - ScienceDirect
JPM, Free Full-Text
Frontiers Indoleamine 2,3-Dioxygenase 1: A Promising Therapeutic Target in Malignant Tumor
Macrophage CD5L is a target for cancer immunotherapy - eBioMedicine
Biology, Free Full-Text
The role of microenvironment in tumor angiogenesis, Journal of Experimental & Clinical Cancer Research
de
por adulto (o preço varia de acordo com o tamanho do grupo)
